Literature DB >> 17101910

Immune reconstitution inflammatory syndrome associated with PML in AIDS: a treatable disorder.

J V Martinez1, J V Mazziotti, E D Efron, P Bonardo, R Jordan, G Sevlever, M Martinez, S C Verbanaz, Z Salazar Salazar, M Fernandez Pardal, R Reisin.   

Abstract

An HIV-1-infected patient with progressive multifocal leukoencephalopathy presented clinical deterioration and contrast-enhancing lesions on brain nuclear MR after the initiation of highly active antiretroviral therapy (HAART). Brain biopsy identified an inflammatory reaction compatible with immune reconstitution inflammatory syndrome. Treatment with corticosteroids and transient suppression of HAART led to marked neurologic improvement.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17101910     DOI： 10.1212/01.wnl.0000242728.26433.12

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


  16 in total

Review 1.  Management of the immune reconstitution inflammatory syndrome.

Authors:  Graeme Meintjes; James Scriven; Suzaan Marais
Journal:  Curr HIV/AIDS Rep       Date:  2012-09       Impact factor: 5.071

Review 2.  Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis.

Authors:  Chen S Tan; Igor J Koralnik
Journal:  Lancet Neurol       Date:  2010-04       Impact factor: 44.182

3.  Inflammatory pseudotumor associated with HIV, JCV, and immune reconstitution syndrome.

Authors:  A Gonzalez-Duarte; S Sullivan; G J Sips; T Naidich; G Kleinman; J Murray; S Morgello; I Germano; M Mullen; D Simpson
Journal:  Neurology       Date:  2009-01-20       Impact factor: 9.910

Review 4.  The immune reconstitution inflammatory syndrome related to HIV co-infections: a review.

Authors:  D Huis in 't Veld; H-Y Sun; C-C Hung; R Colebunders
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-10-02       Impact factor: 3.267

5.  Immune reconstitution inflammatory syndrome: incidence and implications for mortality.

Authors:  Richard M Novak; James T Richardson; Kate Buchacz; Joan S Chmiel; Marcus D Durham; Frank J Palella; Andrea Wendrow; Kathy Wood; Benjamin Young; John T Brooks
Journal:  AIDS       Date:  2012-03-27       Impact factor: 4.177

6.  Immune reconstitution is not a prognostic factor in progressive multifocal leukoencephalopathy.

Authors:  Daniel M Harrison; Scott D Newsome; Richard L Skolasky; Justin C McArthur; Avindra Nath
Journal:  J Neuroimmunol       Date:  2011-08-12       Impact factor: 3.478

Review 7.  Progressive multifocal leukoencephalopathy in HIV-1 infection.

Authors:  Paola Cinque; Igor J Koralnik; Simonetta Gerevini; Jose M Miro; Richard W Price
Journal:  Lancet Infect Dis       Date:  2009-10       Impact factor: 25.071

8.  Progressive multifocal leukoencephalopathy.

Authors:  Allen J Aksamit
Journal:  Curr Treat Options Neurol       Date:  2008-05       Impact factor: 3.598

9.  PML-IRIS in patients with HIV infection: clinical manifestations and treatment with steroids.

Authors:  K Tan; R Roda; L Ostrow; J McArthur; A Nath
Journal:  Neurology       Date:  2009-01-07       Impact factor: 9.910

10.  Progressive Multifocal Leukoencephalopathy in HIV-Infected Children: A Case Report and Literature Review.

Authors:  Peninnah Oberdorfer; Charles H Washington; Kamornwan Katanyuwong; Podjanee Jittamala
Journal:  Int J Pediatr       Date:  2009-09-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.